Logo

American Heart Association

  82
  0


Final ID:

Silent Killer 2- Subclinical ASCVD

  • Savage, Michael  ( Michael Savage , Philadelphia , Pennsylvania , United States )
  • Al-kindi, Sadeer  ( Houston Methodist , Houston , Texas , United States )
  • Blaha, Michael  ( JOHNS HOPKINS HOSPITAL , Baltimore , Maryland , United States )
  • Author Disclosures:
    Michael Savage: DO NOT have relevant financial relationships | Sadeer Al-Kindi: DO have relevant financial relationships ; Research Funding (PI or named investigator):Ionis Pharmaceuticals:Active (exists now) | Michael Blaha: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Eli Lilly:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Agepha:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Idorsia:Past (completed) ; Consultant:Genentech:Past (completed) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Pecha Kucha Says: It’s All About Managing Cardiovascular-Kidney-Metabolic Health

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
The Elephant in the Room: Addressing Excess and Dysfunctional Adiposity

Neeland Ian, Testani Jeffrey, Ndumele Chiadi

The Intersection of Liver and CKM Syndrome

Pandey Ambarish, Sanyal Arun, Mehta Anurag, Mamas Mamas, Rajapreyar Indranee

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available